Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Leyden Labs | 2026 | Undisclosed | $35.2M | Amsterdam |
| LTZ Therapeutics | 2026 | Venture - Series Unknown | $40.0M | San Francisco |
| Aureka Biotechnologies | 2026 | Series A | $23.4M | Laguna Hills |
| Theraheart | 2025 | Series A | $20.6M | Irvine |
| AusperBio | 2025 | Series B | $63.0M | Foster City |
| Fasikl | 2025 | Series B | $26.6M | Bloomington |
| Dualitas Therapeutics | 2025 | Series A | $65.0M | San Francisco |
| Rhino Federated Computing | 2025 | Series A | $15.0M | Boston |
| Soda Health | 2024 | Series B | $54.2M | Chicago |
| Outpace Bio | 2024 | Series B | $144.0M | Seattle |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Leyden Labs | Undisclosed | $35.2M | Amsterdam, The Netherlands |
| 2 | LTZ Therapeutics | Venture - Series Unknown | $40.0M | San Francisco, United States |
| 3 | Aureka Biotechnologies | Series A | $23.4M | Laguna Hills, United States |
| 4 | Theraheart | Series A | $20.6M | Irvine, United States |
| 5 | AusperBio | Series B | $63.0M | Foster City, United States |
| 6 | Fasikl | Series B | $26.6M | Bloomington, United States |
| 7 | Dualitas Therapeutics | Series A | $65.0M | San Francisco, United States |
| 8 | Rhino Federated Computing | Series A | $15.0M | Boston, United States |
| 9 | Soda Health | Series B | $54.2M | Chicago, United States |
| 10 | Outpace Bio | Series B | $144.0M | Seattle, United States |
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Theraheart is a medical device company that offers innovative, minimally invasive solutions for heart failure.
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Fasikl is a neuro-AI company that creates interfaces for the nervous system.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Rhino Federated Computing provides a platform for AI collaboration enterprises to accelerate data strategies and to expand AI use cases.
Soda Health is a healthcare technology company dedicated to eliminating health inequities through social determinants of health.
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
The Clique Compute Coordination Network organizes various heterogeneous compute resources & allocates them efficiently to applications.
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
DeBank creates a cryptocurrency wallet that allows users to access decentralized finance services.
Complete Omics is a developer of multi-omics diagnostics for early disease detection.
Manta Network is building a secure and interoperable future with Zero-Knowledge.
NFTGo is a NFT data aggregator where users can find information about NFT.
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.
Matrixport is a digital assets financial services platform where users can invest, trade, and leverage crypto assets.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Powering precision proteomics to enable to the earliest detection of disease.
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
CODE 27 develops software solutions focused on digital platforms, data systems, and custom technology applications.
Video Rebirth is a private limited company that is established with shares.
Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.
Qiming Venture Partners has invested in 354 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Life Science. The firm invests across 30 different industry categories.
Among tracked funding rounds, Cornerstone Robotics received $200.0M in a Venture - Series Unknown round. Qiming Venture Partners's total known invested capital is $11.0B.
Qiming Venture Partners's average investment size is $54.4M across its portfolio of 354 companies.
Recent Qiming Venture Partners portfolio additions include Leyden Labs, LTZ Therapeutics, Aureka Biotechnologies, Theraheart, AusperBio. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors